Status:
COMPLETED
Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborating Sponsors:
University of Alabama at Birmingham
Conditions:
Chlamydia Infections
Gonorrhea
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Investigators at the University of Alabama in Birmingham in collaboration with investigators from the Centers for Disease Control in Atlanta are evaluating the performance of three commercial nucleic ...
Detailed Description
In the latter part of the 1990's, testing for Chlamydia trachomatis and Neisseria gonorrhoeae infections was revolutionized by the introduction of nucleic acid amplification tests (NAATs) which achiev...
Eligibility Criteria
Inclusion
- Age greater than 15 years.
- If male, history of fellatio, cunnilingus, or receptive anal sex within the last two months.
- If female, presenting for treatment of N. gonorrhoeae and/or C. trachomatis or contact to N. gonorrhoeae, C. trachomatis, or nongonococcal urethritis.
- If female, history of fellatio or history of anal sex within the last two months.
Exclusion
- Declines to participate.
- History of receipt of antimicrobial agents active against N. gonorrhoeae or C. trachomatis in the preceding 30 days.
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
3900 Patients enrolled
Trial Details
Trial ID
NCT00252096
Start Date
June 1 2003
End Date
June 1 2010
Last Update
September 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294